DISTOL-Ext: Digital Ischemic Lesions in Scleroderma Trea

Project: Research project

Project Details


This study is an extension of the DISTOL-1 study that was a placebo controlled medication study for digital ulcers. It allows for those participants who have successfully completed the initial DISTOL-1 study an opportunity to use the drug for up to four
Effective start/end date3/1/108/1/14


  • United Therapeutics Corporation


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.